logo

For the Inventor, By the Inventor

Takarazuka, Japan

Teruo Yamamori

This inventor holds 10 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1980-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruo Yamamori. Retrieved from https://idiyas.com/inventor/teruo-yamamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 60.0

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 59(Granted Patents)


Location History:

  • Nishinomiya, JP (1980)
  • Hyogo, JP (1985 - 1989)
  • Takarazuka, JP (1995 - 2012)

Company Filing History:

goldMedal10 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1980-2012

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8124625 - Method of enhancing the expression of apolipoprotein AI using olefin derivatives (2012-02-28),
2. 8106051 - Utilities of amide compounds (2012-01-31),
3. 8053445 - Utilities of olefin derivatives (2011-11-08),
4. 7429593 - Utilities of amide compounds (2008-09-30),
5. 5473066 - Process for preparing benzothiazepine derivatives (1995-12-05),
6. 5462936 - Benzothiazepine derivatives (1995-10-31),
7. 5378698 - Benzothiazepine derivatives (1995-01-03),
8. 4873334 - 4,7-dihydropyrazolo(3,4-b) pyridine derivatives (1989-10-10),
9. 4562256 - 1,6-Dialkyl-3-su (1985-12-31),
10. 4190728 - Process for the production of lower alkyl 2-chloro-2-hydroxyiminoacetates (1980-02-26),

Title: Teruo Yamamori: Innovator in Pharmaceutical Chemistry

Introduction

Teruo Yamamori is a renowned inventor based in Takarazuka, Japan, recognized for his significant contributions to pharmaceutical chemistry. With a portfolio consisting of ten patents, Yamamori has established himself as a key figure in the innovation of compounds that enhance health outcomes.

Latest Patents

Among his latest patents, Yamamori has developed a method for enhancing the expression of apolipoprotein AI using olefin derivatives. The compounds he has innovated include a detailed formula that allows for the enhancement of apoAI expression, showcasing a thorough understanding of medicinal chemistry. Patents disclose the utilities of amide compounds, which serve as potential medicaments, further emphasizing his contributions to the pharmaceutical field.

Career Highlights

Yamamori is affiliated with Shionogi & Company Limited, a prominent pharmaceutical company. His work at Shionogi is characterized by rigorous research and development aimed at creating effective therapeutic solutions. His portfolio reflects his emphasis on developing compounds that impact human health positively.

Collaborations

Throughout his career, Teruo Yamamori has collaborated with various talented professionals, including Katsunori Sakai and Kiyoshi Nagata. These collaborations have fostered an environment of innovation and discovery in the realm of pharmaceutical advancements.

Conclusion

Teruo Yamamori's contributions to the field of pharmaceutical chemistry through his innovative patents and collaborations place him as a respected inventor in the industry. His commitment to enhancing health outcomes through advanced compounds continues to influence the future of medicinal research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…